
UAE: Taking a break from work to hit the gym? How executives can model work-life balance
Healthy work environments begin with what employees see from their leaders — not just what they're told.
Culture shifts through example, not just memos. That was the message echoed by HR leaders during the Future Workforce Summit 2025, held at the Address Sky View Hotel in Dubai, where work-life harmony took centre-stage as a critical pillar of modern workplace culture.
At the summit, Anam Irfan, an HR executive and wellness advocate, said, 'There's no such thing as perfect balance,' she said. 'But harmony is achievable — if leaders model it. Employees are watching. What we normalise from the top is what becomes culture.'
She recounted an example from her own experience working with a C-suite executive in a major digital firm in the GCC. The executive prioritised his personal wellness by blocking time mid-day to visit the gym — a small act that led to a 25 per cent to 30 per cent increase in employees doing the same.
'When the leader made wellness visible and unapologetic, others felt safe to follow,' Irfan added. 'That's how culture shifts — through example, not just memos.'
Irfan also pointed out that in the GCC region, many professionals — especially expatriates — face heightened job insecurity, which makes it even more crucial for leaders to signal that taking care of one's health is not just acceptable but expected.
'This isn't like being in your home country where job transitions feel safe. Here, people hold on tightly to their roles. That's why leadership's role in normalising balance is even more vital,' she said.
Culture and accountability go hand-in-hand
The Future Workforce Summit 2025, organised by KT Events and held at the Address Sky View Hotel in Dubai, is designed to spark vital conversations about the workplace and challenge traditional norms in the UAE and beyond.
Mirray Fahim, People & Organisation Director at Novo Nordisk UAE, expanded on this message with concrete examples of how accountability for wellness is embedded at every level of her organisation.
'We don't just talk about wellness — we measure it,' she said. 'You can't manage what you don't measure.'
At Novo Nordisk, an annual engagement survey called Evolve includes dedicated questions about stress, physical well-being, and whether employees feel their company cares about them. These results aren't just stored in HR files — they're tied to leadership performance reviews and even bonuses.
'Leaders are held accountable. If their teams show low engagement or high stress, they're enrolled in targeted support programs with organisational psychologists to unpack the 'why' and improve,' Fahim shared.
She emphasised that the data shows a clear link — high engagement correlates strongly with lower stress, and the reverse is also true. For Novo Nordisk, wellness is not a 'nice to have' but a business imperative.
Prevention pays off — literally
Fahim also highlighted Novo Nordisk's global initiative, NovoHealth, which focuses on six pillars of preventive care — including mental health, fitness, and regular health checks.
'We offer every employee gym memberships, yoga classes, even a home treadmill,' she noted. 'Some might say that's a luxury. But our insurance data shows it saves us 2 to 4 times the cost over time, when we prevent chronic conditions.'
This long-term view, she explained, has led the company to design benefits that span life stages — whether it's 14 weeks of paid parental leave, fully paid caregiver leave for employees with aging parents, or remote work flexibility for those going through personal challenges.
She closed with a deeply human example — when an employee dealing with a high-risk pregnancy asked for extended unpaid leave, the company instead worked with her to redesign her role to be remote-friendly — ensuring her health, income, and peace of mind were all preserved.
'We saw her as a whole person, not just a worker. That's what wellness really means.'
The session made it clear that the future of healthy workplaces lies not in slogans or superficial benefits, but in the willingness of leaders to model wellness, take accountability for their teams' emotional climate, and treat employees as humans first.
As Irfan put it, 'if we want healthier workspaces, the change has to start with us. We build the blueprint through our behavior. Culture is contagious.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Khaleej Times
20-05-2025
- Khaleej Times
UAE: Taking a break from work to hit the gym? How executives can model work-life balance
Healthy work environments begin with what employees see from their leaders — not just what they're told. Culture shifts through example, not just memos. That was the message echoed by HR leaders during the Future Workforce Summit 2025, held at the Address Sky View Hotel in Dubai, where work-life harmony took centre-stage as a critical pillar of modern workplace culture. At the summit, Anam Irfan, an HR executive and wellness advocate, said, 'There's no such thing as perfect balance,' she said. 'But harmony is achievable — if leaders model it. Employees are watching. What we normalise from the top is what becomes culture.' She recounted an example from her own experience working with a C-suite executive in a major digital firm in the GCC. The executive prioritised his personal wellness by blocking time mid-day to visit the gym — a small act that led to a 25 per cent to 30 per cent increase in employees doing the same. 'When the leader made wellness visible and unapologetic, others felt safe to follow,' Irfan added. 'That's how culture shifts — through example, not just memos.' Irfan also pointed out that in the GCC region, many professionals — especially expatriates — face heightened job insecurity, which makes it even more crucial for leaders to signal that taking care of one's health is not just acceptable but expected. 'This isn't like being in your home country where job transitions feel safe. Here, people hold on tightly to their roles. That's why leadership's role in normalising balance is even more vital,' she said. Culture and accountability go hand-in-hand The Future Workforce Summit 2025, organised by KT Events and held at the Address Sky View Hotel in Dubai, is designed to spark vital conversations about the workplace and challenge traditional norms in the UAE and beyond. Mirray Fahim, People & Organisation Director at Novo Nordisk UAE, expanded on this message with concrete examples of how accountability for wellness is embedded at every level of her organisation. 'We don't just talk about wellness — we measure it,' she said. 'You can't manage what you don't measure.' At Novo Nordisk, an annual engagement survey called Evolve includes dedicated questions about stress, physical well-being, and whether employees feel their company cares about them. These results aren't just stored in HR files — they're tied to leadership performance reviews and even bonuses. 'Leaders are held accountable. If their teams show low engagement or high stress, they're enrolled in targeted support programs with organisational psychologists to unpack the 'why' and improve,' Fahim shared. She emphasised that the data shows a clear link — high engagement correlates strongly with lower stress, and the reverse is also true. For Novo Nordisk, wellness is not a 'nice to have' but a business imperative. Prevention pays off — literally Fahim also highlighted Novo Nordisk's global initiative, NovoHealth, which focuses on six pillars of preventive care — including mental health, fitness, and regular health checks. 'We offer every employee gym memberships, yoga classes, even a home treadmill,' she noted. 'Some might say that's a luxury. But our insurance data shows it saves us 2 to 4 times the cost over time, when we prevent chronic conditions.' This long-term view, she explained, has led the company to design benefits that span life stages — whether it's 14 weeks of paid parental leave, fully paid caregiver leave for employees with aging parents, or remote work flexibility for those going through personal challenges. She closed with a deeply human example — when an employee dealing with a high-risk pregnancy asked for extended unpaid leave, the company instead worked with her to redesign her role to be remote-friendly — ensuring her health, income, and peace of mind were all preserved. 'We saw her as a whole person, not just a worker. That's what wellness really means.' The session made it clear that the future of healthy workplaces lies not in slogans or superficial benefits, but in the willingness of leaders to model wellness, take accountability for their teams' emotional climate, and treat employees as humans first. As Irfan put it, 'if we want healthier workspaces, the change has to start with us. We build the blueprint through our behavior. Culture is contagious.'


Zawya
16-05-2025
- Zawya
Obesity drug maker Novo Nordisk's CEO to step down amid market struggle
Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price amid intensifying competition in the obesity drug market. "The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company's share price since mid-2024," Novo said in a statement. Under his leadership, Novo Nordisk became a first-mover in the obesity and diabetes drug market, with sky-rocketing sales of its Wegovy and Ozempic treatments. Investors have however been concerned that Novo's first-to-market obesity drug is losing its lead to Eli Lilly , whose U.S. prescriptions for its Zepbound obesity shot have surpassed Wegovy since mid-March. Novo Nordisk's share price fell 2.2% by 1116 GMT. It is down 32% year-to-date. Jorgensen, who joined Novo Nordisk in 1991 and has been CEO since 2017, will continue as CEO for a transition period and a search for his successor is ongoing, it added. (Reporting by Stine Jacobsen and Jacob Gronholt-Pedersen, editing by Terje Solsvik)


Gulf Today
14-05-2025
- Gulf Today
EU scramble to interpret Trump's new drug pricing order
Maggie Fick, Reuters European governments are examining whether US President Donald Trump can force them to pay more for prescription medicines, after he issued an executive order to lower US drug prices, roiling the global pharmaceutical industry. On Monday, Trump took aim at governments paying a fraction of what Americans have to shell out for their medicines, and directed the use of trade policy to force other nations to pay more for prescription drugs. The Trump administration wants to reduce the gap between US drug prices and those in other developed countries such as many in Europe, where prescription drugs cost, on average, one-third what they do in the United States. Denmark's industry and business minister Morten Bodskov plans to meet with drugmakers based in his country to discuss the order. He did not give details about the meeting. 'The uncertainty (caused) by the US is bad for the world,' he told Reuters. 'Danish pharmaceutical companies are among the best in the world and are of great importance to Denmark. The message from Trump does not change that.' The country of six million has benefited from the expansion of Novo Nordisk and the outsize demand for its diabetes drug Ozempic and for Wegovy, one of the powerful new weight-loss drugs singled out by Trump in his push to lower prices. Novo, Europe's third-largest listed company worth 265 billion euros ($295.74 billion), said it looked forward to the meeting. In the US, drug prices are shaped by complex negotiations involving pharmacy benefit managers that act as middlemen between drugmakers and employer clients and health insurers and have been criticised for inflating costs. In Europe, countries generally have public health systems that negotiate directly with manufacturers and keep costs down. The European Commission, the EU executive, will assess the impact of Trump's order on European companies, a spokesperson told reporters on Tuesday. 'We know the pharmaceutical industry faces challenges both in the US and the EU,' the spokesperson said, noting Commission President Ursula von der Leyen had met with executives last month to address concerns about the threat of US tariffs on medicines. Trump's effort during his first term through a more limited executive order focused on certain drugs covered by the government's Medicare program — was blocked by a court. Trump said if drugmakers do not cut prices they could be hit with tariffs. His administration launched a probe last month into pharmaceutical imports as a potential precursor to placing levies on medicines on national security grounds. 'The United States will no longer subsidize the healthcare of foreign countries, which is what we were doing,' Trump said on Monday. 'I'm not knocking the drug companies. I'm really more knocking the countries than the drug companies.' Although Americans pay significantly more for medicines, they have access to a greater number of treatments. Some 55% more cancer drugs were launched in the U.S. than in the UK over the past three decades, according to a 2024 study in the British Medical Journal. An AstraZeneca spokesperson said the company supports fairer global sharing of pharmaceutical costs, but that changes must avoid 'disrupting patient care, undermining U.S. biotech leadership, or stifling innovation.' Seven drug pricing experts and lawyers told Reuters it is unclear how the administration could legally demand confidential contract details between drugmakers and governments. That information would be needed as Trump's order calls for giving drugmakers price targets within a month. Strict cost containment measures and reimbursement policies prevent drugmakers from charging Britain's financially strapped state-funded National Health Service more for new drugs, said Daniel Howdon, a health economist at the University of Leeds. 'Unless there is some sort of overhaul of UK law or policy, Trump's order will not be able to achieve higher prices,' he said. A spokesperson for Germany's health ministry told Reuters it was not possible to predict how the U.S. order may be implemented. Germany has a 'clearly defined framework for price negotiations on medicines between statutory health insurance and the pharmaceutical industry,' the spokesperson said. The call for developed countries to pay more for drugs so the U.S. can pay less comes as worries grow that uncertainty caused by Trump's whiplash trade war will dampen the 27-nation bloc's already-weak economy. Even with the threat of tariffs, governments may be unable and unwilling to spend more on medicines, particularly as populations age and healthcare budgets tighten, UBS analyst Trung Huynh said. The UK government does not publish the prices it pays for NHS drugs, but a source at the UK's Department of Health and Social Care said prices for some treatments are about a quarter of those paid by the U.S. The DHSC did not respond to a request for comment. Still, a source at a European drugmaker told Reuters the Trump administration could still exert pressure to try to force governments to alter their longstanding pricing practices embedded in national health systems. 'I read this as him showing pharma all of the negotiating tools he has at his disposal,' said Anna Kaltenboeck, a health economist at Verdant Research, 'and giving them some credible threat based on his willingness to impose tariffs so far.'